Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients

19 Jul 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma Diagnosis and Treatment
Share to Multiple and Secondary Primary Cancers
Share to Ocular Oncology and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35863105
DOI: 10.1016/j.ejca.2022.06.033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patientsPMID 35863105Read ↗

Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumabSemantic proximity Read ↗

Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors.Semantic proximity Read ↗

Germline loss‐of‐function variants in MBD4 are rare in Finnish patients with uveal melanomaSemantic proximity Read ↗

Germline MBD4 Mutations and Predisposition to Uveal Melanoma.Semantic proximity Read ↗

Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants.Semantic proximity Read ↗

MTMR14 as a novel prognostic predictor and potential immunotherapy target in uveal melanomaSemantic proximity Read ↗

Mutated ERBB4: a novel drug target in metastatic melanoma?Semantic proximity Read ↗

Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.Semantic proximity Read ↗

BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic TherapySemantic proximity Read ↗

Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patientsSemantic proximity Read ↗

Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathway.Semantic proximity Read ↗

The Cell-Cycle Regulator CDK4: An Emerging Therapeutic Target in MelanomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.